1.Experimental hypercholesterolemia induces ultrastructural changes in the elastic laminae of rabbit aortic valve.
Hyuck Moon KWON ; Byoung Kwon LEE ; Dongsoo KIM ; Bum Kee HONG ; Ki Hyun BYUN ; June Sick KNA ; In Jai KIM ; Soo Hwan OH ; Hyun Seung KIM
Yonsei Medical Journal 1998;39(4):345-354
Atherosclerosis is the most severe problem in the high-pressure systemic circulation and similar changes also occur in the high-pressure loading valve. This study was designed to test the hypothesis that early atherosclerosis, induced by a high cholesterol diet in rabbits, is characterized by significant ultrastructural change in the elastic laminae of the aortic valve. However, it is not known whether this process is also taking place in the cardiac valve at the early stage of atherosclerosis. Animals were fed either a high cholesterol diet (n = 5) or a control diet (n = 5) for 10-12 weeks. Histologic analysis demonstrated that subendothelial thickening and foam-cell infiltration were evident in the arterialis of aortic valves. Confocal microscopy revealed an altered pattern characterized by fragmentation and disorganization of the arterialis elastic laminae of hypercholesterolemic valves. Computerized digital analysis of the images obtained by confocal scanning microscopy demonstrated that compared to normal valves, the arterialis elastic laminae of hypercholesterolemic valves decreased in percentage of their elastin content (29.03 +/- 1.10% vs. 42.94 +/- 1.35%, p = 0.023). Immunohistochemical staining for matrix metalloproteinase-3 (MMP-3) revealed MMP-3 immunoreactivity was increased in hypercholesterolemic valves, predominantly in the arterialis. This study demonstrated that early atherosclerosis, induced by a high cholesterol diet in rabbits, is characterized by significant ultrastructural change in the elastic laminae of the aortic valve. The arterialis endothelium of the aortic valve may be a more atherosclerosis-prone area compared with the ventricularis. The presence of ultrastructural defect in the elastic laminae may play a role in chronic degenerative change and a resultant valvular dysfunction.
Animal
;
Aortic Valve/ultrastructure*
;
Elastic Tissue/ultrastructure*
;
Hypercholesterolemia/pathology*
;
Male
;
Microscopy, Confocal
;
Rabbits
;
Stromelysin 1/metabolism
2.Interferon-gamma upregulates the stromelysin-1 gene expression by human skin fibroblasts in culture.
Kyu Suk LEE ; Young Wook RYOO ; Joon Young SONG
Experimental & Molecular Medicine 1998;30(2):59-64
The equilibrium between deposition and degradation of extracellular matrix(ECM) is essential to normal tissue development and repair of wound or inflammatory responses. It has recently become apparent that several cytokines and growth factors are capable of modulating fibroblast proliferation and biosynthetic activity. To understand the role of these factors in connective tissue regulation, we examined the effect of interferon-gamma (IFN-gamma) on stromelysin-1 gene expression in cultured human dermal fibroblasts. The steady-state levels of stromelysin-1 mRNA were increased in IFN-gamma treated cultured dermal fibroblasts. In the CAT assay, the stromelysin-1 promoter activity was increased 2.8-fold compared with untreated control. Therefore IFN-gamma stimulates the stromelysin-1 promoter activity, resulting in transcriptional enhancement of gene expression. Transforming growth factor-beta (TGF-beta) showed the antagonistic action to the effects of IFN-gamma in cultured dermal fibroblasts. Furthermore, gel mobility shift assays demonstrated enhanced AP-1 binding activities in nuclear extracts from cells incubated with IFN-gamma. These data suggest that IFN-gamma is an up-regulator and TGF-beta is a down regulator on the stromelysin-1 gene expression, respectively, and the AP-1 binding site may be necessary for gene response.
Cell Nucleus
;
Cells, Cultured
;
Chloramphenicol O-Acetyltransferase/metabolism
;
Chloramphenicol O-Acetyltransferase/genetics
;
Collagenases/genetics
;
Collagenases/drug effects
;
Fibroblasts/metabolism
;
Fibroblasts/drug effects*
;
Gene Expression Regulation/drug effects
;
Human
;
Interferon Type II/pharmacology*
;
Promoter Regions (Genetics)
;
Recombinant Proteins/metabolism
;
Recombinant Proteins/genetics
;
Skin/cytology*
;
Stromelysin 1/metabolism*
;
Stromelysin 1/genetics*
;
Stromelysin 1/drug effects
;
Transcription Factor AP-1/metabolism
;
Transcription, Genetic
;
Transforming Growth Factor beta/pharmacology
;
Up-Regulation (Physiology)
3.Ultrastructural changes of the external elastic lamina in experimental hypercholesterolemic porcine coronary arteries.
Hyuck Moon KWON ; Seokmin KANG ; Bum Kee HONG ; Dongsoo KIM ; Hyun Young PARK ; Mi Seung SHIN ; Ki Hyun BYUN
Yonsei Medical Journal 1999;40(3):273-282
The external elastic lamina (EEL) serves as a barrier for cells and macromolecules between the media and adventitia in the vascular wall. We evaluated the morphological changes and quantitative assessments of the EEL architecture in the coronary circulation of pigs fed with a high cholesterol diet. Confocal microscopy analysis of the EEL from hypercholesterolemic coronary arteries revealed an altered pattern characterized by fragmentation and disorganization of the EEL associated with an increase in the thickness. Computerized digital analysis of the images obtained by confocal scanning microscopy demonstrated that compared to normal coronary arteries, the EEL of hypercholesterolemic coronary arteries decreased in the percentage of their elastin content (30.80 +/- 1.64% vs. 47.85 +/- 1.82%, p = 0.001). The percentage of elastin content was negatively correlated with the vessel wall area (r = -0.82, p = 0.001). The immunoreactivity for matrix metalloproteinase-3 (MMP-3) increased in cholesterol-fed coronary arteries, predominantly in the neointima and adventitia. This study demonstrates that experimental hypercholesterolemia induced ultrastructural changes of the EEL in coronary circulation. The EEL may also be an atherosclerosis-prone area compared with the intima. The EEL may play an important role in the development of structural changes which characterizes the early phase of coronary atherosclerosis and vascular remodeling.
Animal
;
Arteries/ultrastructure
;
Arteries/enzymology
;
Coronary Vessels/ultrastructure*
;
Coronary Vessels/enzymology
;
Elastic Tissue/ultrastructure*
;
Elastic Tissue/enzymology
;
Female
;
Hypercholesterolemia/pathology*
;
Hypercholesterolemia/enzymology
;
Stromelysin 1/metabolism
;
Swine
4.Genistein Supplementation Inhibits Atherosclerosis with Stabilization of the Lesions in Hypercholesterolemic Rabbits.
Choong Sik LEE ; Su Jin KWON ; Sun Young NA ; Seung Pyung LIM ; Jung Hee LEE
Journal of Korean Medical Science 2004;19(5):656-661
The effect of genistein on aortic atherosclerosis was studied by immunohistochemistry with RAM-11 and HHF-35 antibodies and western blotting for matrix metalloproteinase-3 (MMP-3) in New Zealand White rabbits. After provocation of atherosclerosis with hyperlipidemic diet, the rabbits were divided as hyperlipidemic diet group (HD), normal diet group (ND) and hyperlipidemic plus genistein diet group (HD+genistein) for 4 and half months. The average cross sectional area of atherosclerotic lesion was 0.269 mm2 after provocation. The lesion was progressed by continuous hyperlipidemic diet (10.06 mm2) but was increased mildly by genistein (0.997 mm2), and decreased by normal diet (0.228 mm2). The ratio of macrophages to smooth muscle cells in the lesion was not changed by genistein supplementation. The western blotting showed reduction of MMP-3 expression in HD+genistein and ND groups than HD group. The inhibition of atherogenesis by genistein was might be due to improve the endothelial dysfunction rather than direct action on macrophages and/or smooth muscle cells in the lesion, since endothelial dysfunction by lipid peroxidation was the main atherogenic factor in the hypercholesterolemicrabbits. The genistein supplementation also suggests that it helps the stabilization of the atherosclerotic lesion by inhibition of MMP-3 expression.
Animals
;
Aorta/pathology
;
Arteriosclerosis/*drug therapy/pathology/*prevention & control
;
Blotting, Western
;
Diet, Atherogenic
;
Genistein/*pharmacology
;
Growth Inhibitors/*pharmacology
;
Hypercholesterolemia/*drug therapy/pathology
;
Macrophages/pathology
;
Male
;
Muscle, Smooth, Vascular/enzymology/pathology
;
Rabbits
;
Research Support, Non-U.S. Gov't
;
Stromelysin 1/metabolism